GlaxoSmithKline Consumer Healthcare Pakistan : CTC of Special Resolutions Passed in the Extraordinary General Meeting 2022

5 December 2022

The General Manager

Pakistan Stock Exchange Limited,

Stock Exchange Building,

Stock Exchange Road,

Karachi.

Subject:

Certified True Copy of Special Resolutions

Dear Sir / Madam,

In accordance with clause 5.6.9 (b) of the Rule Book of the Pakistan Stock Exchange Limited, we are pleased to enclose a certified true copy of special resolutions passed by the shareholders in the Extraordinary General Meeting held on 5 December 2022.

Thank you.

For and on behalf of

GlaxoSmithKline Consumer Healthcare Pakistan Limited

Mashal Mohammad

Company Secretary

Enclosed: As above

Cc: Executive Director/HOD

Offsite-II Department, Supervision Division,

Securities and Exchange Commission of Pakistan,

63, NIC Building, Jinnah Avenue,

Blue Area, Islamabad.

1

EXTRACT FROM THE DRAFT MINUTES OF THE THIRD EXTRAORDINARY GENERAL

MEETING OF GLAXOSMITHKLINE CONSUMER HEALTHCARE PAKISTAN LIMITED HELD

ON 5 DECEMBER 2022

1. To consider and approve the change of the name of the Company from 'GlaxoSmithKline Consumer Healthcare Pakistan Limited' to 'Haleon Pakistan Limited' and to pass the following special resolution.

IT WAS RESOLVED THAT the name of the Company be changed from 'GlaxoSmithKline Consumer Healthcare Pakistan Limited' to 'Haleon Pakistan Limited' subject to relevant regulatory and shareholder approvals, with effect from the date of the Certificate of Incorporation on Change of Name issued by the Securities and Exchange Commission of Pakistan.

IT WAS FURTHER RESOLVED THAT upon the change of the name being approved by the Registrar of Companies, the Memorandum and Articles of Association of the Company shall be altered by the change of the name of the Company from 'GlaxoSmithKline Consumer Healthcare Pakistan Limited' to 'Haleon Pakistan Limited' wheresoever appearing in the said Memorandum and Articles of Association.

IT WAS FURTHER RESOLVED THAT the Chief Executive Officer, and /or the Chief Financial Officer and

• or the Company Secretary be and are hereby authorized to jointly and / or severally do all such acts, deeds and things as may be deemed necessary or ancillary to give effect to the foregoing resolution including without limitation to take actions and execute documents as may be necessary for the purpose of changing the name of the Company and to alter the Memorandum and Articles of Association, including, but not limited to, filing the requisite applications before the Securities and Exchange Commission of Pakistan and to sign all statutory returns, forms, notices, circulars and documents as may be required in connection with these resolutions.

1. To consider and approve the alteration in the Memorandum and Articles of Association of the Company in order to align the same with the Companies Act, 2017.

IT WAS RESOLVED THAT the alteration to the Memorandum and Articles of Association of the Company to align these with the Companies Act, 2017 be and is hereby approved.

IT WAS FURTHER RESOLVED THAT the Chief Executive Officer, and / or the Chief Financial Officer and

• or the Company Secretary be and are hereby authorized to jointly and / or severally do all such acts, deeds and things as may be deemed necessary or ancillary to give effect to the foregoing resolution including without limitation to take actions and execute documents as may be necessary for the purpose of altering the Memorandum and Articles of Association, including, but not limited to, filing the requisite applications before the Securities and Exchange Commission of Pakistan and to sign all statutory returns, forms, notices, circulars and documents as may be required in connection with these resolutions.

CERTIFIED TRUE COPY

Mashal Mohammad

Company Secretary

2